Neoantigens derived from oncogenic gene fusions can elicit T-cell responses in tumors with low TMB. Click to show full abstract
Neoantigens derived from oncogenic gene fusions can elicit T-cell responses in tumors with low TMB.
               
Click one of the above tabs to view related content.